Cell surface regulators of complement, 512 antigen, and CD59, in the rat eye and adnexal tissues

被引:0
|
作者
Bardenstein, DS
Cheyer, C
Okada, N
Morgan, BP
Medof, ME
机构
[1] Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr Vis Res, Cleveland, OH 44106 USA
[3] Nagoya City Univ, Sch Med, Dept Mol Biol, Nagoya, Aichi 467, Japan
[4] Cardiff Univ, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Cell surface complement regulatory proteins have been identified in high levels in ocular tissues, but no experimental model is available for examining their physiological roles. To develop such a model, the distribution of 512 antigen, a protein possessing the functions of the human decay-accelerating factor (DAF [CD55]) and membrane cofactor protein (MCP [CD46]), and rat inhibitory protein (CD59), the homologue of the human membrane inhibitor of reactive lysis (MIRL[CD59]) were characterized in the rat eye and ocular adnexal structures. METHODS. After euthanasia of female Wistar rats, followed by orbital exenteration, eyelids and orbital tissue including the lacrimal gland were separated from the globes and immediately snap-frozen in liquid nitrogen at -70 degrees C. Tissues then were sectioned at -20 degrees C and examined immunohistochemically for 512 antigen and rat CD59. RESULTS. Both molecules were found to be present in high levels in multiple sites. Corneal and conjunctival epithelia showed moderate to intense labeling for both regulators. Fibroblasts in the corneal stroma, conjunctiva, and sclera labeled similarly. Corneal endothelial cells showed intense labeling for rat CD59 but not for 512 antigen. The iris and ciliary body showed intense labeling for both proteins. The retina showed labeling at multiple levels, with that of rat CD59 being more intense than that of 512 antigen. The lacrimal gland labeled for both regulators. Vessels, muscle, and nerves in the orbit labeled intensely for both antigens. In the eyelid, conjunctiva, sebaceous glands, and muscle and nerve tissues labeled moderately to intensely for both molecules, whereas skin epithelium labeled less intensely. CONCLUSIONS. 512 antigen and rat CD59 are expressed in high levels and distributed similarly in the rat eye and lacrimal gland to DAF, MCP, and MIRL in the human eye and lacrimal gland. These findings establish the rat ocular surface as a model for studying the role of cell surface complement regulators in this site. This first identification of copious expression of these proteins in eyelid structures. which also participate in protection of the ocular surface, further suggests an important role for surface complement regulatory proteins in this location.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [1] Complement regulators CD55 and CD59 are differentially distributed during red blood cell enucleation
    de Boer, Esther C. W.
    Thielen, Astrid J. F.
    Visser, Anna
    Kamp, Angela
    Wouters, Diana
    Burger, Patrick
    Tol, Simon
    Yagci, Nurcan
    von Lindern, Marieke M.
    van den Akker, Emile
    Jongerius, Ilse
    Pouw, Richard
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 117 - 117
  • [2] Binding of human and rat CD59 to the terminal complement complexes
    Lehto, T
    Morgan, BP
    Meri, S
    IMMUNOLOGY, 1997, 90 (01) : 121 - 128
  • [3] Complement regulators Cl inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease
    Yasojima, K
    McGeer, EG
    McGeer, PL
    BRAIN RESEARCH, 1999, 833 (02) : 297 - 301
  • [4] Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation
    Mizuno, Tomohiro
    Mizuno, Masashi
    Morgan, B. Paul
    Noda, Yukihiro
    Yamada, Kiyofumi
    Okada, Noriko
    Yuzawa, Yukio
    Matsuo, Seiichi
    Ito, Yasuhiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) : 1821 - 1830
  • [5] Identification of mutations in rat CD59 that increase the complement regulatory activity
    Hinchliffe, SJ
    Morgan, BP
    BIOCHEMISTRY, 2000, 39 (19) : 5831 - 5837
  • [6] Elimination of potential sites of glycosylation fails to abrogate complement regulatory function of cell surface CD59
    Rother, RP
    Zhao, J
    Zhou, QS
    Sims, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 23842 - 23845
  • [7] Regulators of complement: Biological roles and applications to therapy the unique complement regulator CD59: Functional characterisation and gene deletion
    Morgan, BP
    MEDICINA-BUENOS AIRES, 2000, 60 (05) : 680 - 680
  • [8] MODULATION OF PROTECTIN (CD59 ANTIGEN) CELL-SURFACE EXPRESSION ON HUMAN NEOPLASTIC CELL-LINES
    SEDLAK, J
    HUNAKOVA, L
    DURAJ, J
    GROFOVA, M
    CHORVATH, B
    NEOPLASMA, 1993, 40 (06) : 337 - 340
  • [9] DISTRIBUTION OF PROTECTIN-(CD59), A COMPLEMENT MEMBRANE ATTACK INHIBITOR, IN NORMAL HUMAN TISSUES
    MERI, S
    WALDMANN, H
    LACHMANN, PJ
    LABORATORY INVESTIGATION, 1991, 65 (05) : 532 - 537
  • [10] Levels of lymphocyte-associated regulators of complement system CD55 and CD59 are changed in schizophrenia patients
    Togay, Alper
    Togay, Bilge
    Gediz, Deniz Ozbay
    Akbas, Sadika Halide
    Koksoy, Sadi
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2021, 25 (03) : 277 - 282